Suchergebnisse - (Subject:"PARP inhibitor")

PubPharm (138)

11

Cross-Resistance between Platinum-Based Chemotherapy and PARP Inhibitors in Castration-Resistant Prostate Cancer

enthalten in: Cancers | 2023

von Slootbeek, P. | Kloots, I. | van Oort, I. | +4

12

Roles of the PARP Inhibitor in BRCA1 and BRCA2 Pathogenic Mutated Metastatic Prostate Cancer : Direct Functions and Modification of the Tumor Microenvironment

enthalten in: Cancers | 2023

von Inoue, T. | Sekito, S. | Kageyama, T. | +2

13

Management of Advanced Prostate Cancer in the Precision Oncology Era

enthalten in: Cancers | 2023

von Gillette, C. | Yette, G. | Cramer, S. | +1

14

PARP Inhibitors in Breast and Ovarian Cancer

enthalten in: Cancers | 2023

von Wang, S. | Jie, Y. | Cheng, S. | +2

15

Advances in PARP Inhibitors for Prostate Cancer

enthalten in: Cancers | 2023

von Tisseverasinghe, S. | Bahoric, B. | Anidjar, M. | +2

16

Radiotherapy, PARP Inhibition, and Immune-Checkpoint Blockade : A Triad to Overcome the Double-Edged Effects of Each Single Player

enthalten in: Cancers | 2023

von Rosado, M. | Pioli, C.

17

Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer : The MITO 37 Retrospective Study

enthalten in: Cancers | 2023

von Tuninetti, V. | Ghisoni, E. | Pignata, S. | +22

18

Implementing HRD Testing in Routine Clinical Practice on Patients with Primary High-Grade Advanced Ovarian Cancer

enthalten in: Cancers | 2023

von Heitz, F. | Ataseven, B. | Staniczok, C. | +12

19

Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective Study

in: Cancers | 2023

von Valentina Tuninetti | Eleonora Ghisoni | Sandro Pignata | +22

20

Advances in PARP Inhibitors for Prostate Cancer

in: Cancers | 2023

von Steven Tisseverasinghe | Boris Bahoric | Maurice Anidjar | +2